Immune evasion in malaria altered peptide ligands of the circumsporozoite protein

Parasitology

Volumn 115, Issue 7, 1997, Pages 55-66

  Plebanski, M ^a   Lee, E A M ^a   Hill, A V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 6544273487     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182097002035     Document Type: Article

References (101)

1. AIDOO, M., LALVANI, A., ALLSOPP, C. E. M., PLEBANSKI, M., MEISNER, S. J., KRAUSA, P., BROWNING, M., MORRIS JONES, S., GOTCH, F., FIDOCK, D. A., TAKIGUCHI, M.ROBSON, K. J. H., GREENWOOD, B. M., DRUILHE, P., whittle, h. c. & hill, a. v. s. (1995). Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345, 1003 1007.
2. AL YAMAN, F., GENTON, B., ANDERS, R., TARAIKA, J., GINNY, M., MELLOR, S. & ALPERS, M. P. (1995). Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunology 17, 493–501.
3. ALLSOPP, C. E. M., PLEBANSKI, M., GILBERT, S., SINDEN, R. E., HARRIS, S., FRANKEL, G., DOUGAN, G., HIOE, C., NIXON, D., PAOLETTI, E., LAYTON, G. & HILL, A. V. S. (1996). Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. European Journal of Immunology 26, 1951–1959.
4. ALONSO, P. L., SMITH, T., SCHELLENBERG, J. R., MASANJA, H., MWANKUSYE, S., URASSA, H., BASTOS DE AZEVEDO, I., CHONGELA, J., KOBERO, S., MENENDEZ, C., HURT, N., THOMAS, M. C., LYIMO, E., WEISS, N. A., HAYES, R., KITUAXUJE, A. Y., LOPEZ, M. C., KILAMA, W. L., TEUSCHER, T. & TANNER, M. (1994). Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344, 1175–1181.
5. ANDERSSON, M., PAABO, S., NILSSON, T. & PETERSON, P. A. (1985). Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43, 215–222.
6. BALLOU, W. R., BLOOD, J., CHONGSUPHAJAISSIDHI, T., GORDON, D. M., HEPPNER, D. G., KYLE, D. E., LUXEMBURGER, C., NOSTEN, F., SADOFF, J. C., SINGHASIVANON, P., WHITE, N. J., WEBSTER, K. H., WITTES, J. & WONGSRICHANALAI, c. (1995). Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase lib efficacy study. Parasitology 110, S25-S36.
7. BALLOU, W. R., ROTHBARD, J., WIRTZ, R. A., GORDON, D. M., WILLIAMS, J. S., GORE, R. W., SCHNEIDER I., HOLLINGDALE, M. R., BEAUDOIN, R. L., MALOY, W. L., MILLER, L. H. & HOCKMEYER, W. T. (1985). Immunogenicity of synthetic peptides from the circumpsorozoite protein of Plasmodium falciparum. Science 228, 996–999.
8. BECK, H. P., FELGER, I., KABINTIK, S., TAVUL, L., GENTON, B., ALEXANDER, N., BHATIA, K. K., AL YAMAN, F., HII, J. & ALPERS, M. (1994). Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea. American Journal of Tropical Medicine and Hygiene 51, 356–364.
9. BEERSMA, M. F., BIJLMAKERS, M. J. & PLOEGH, H. L. (1993). Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. Journal of Immunology 151, 4455–4464.
10. BERTOLETTI, A., COSTANZO, A., CHISARI, F. V., LEVRERO, M., ARTINI, M., SETTE, A., PENNA, A., GIUBERTI, T., FIACCADORI, F. & FERRARI, c. (1994a). Cytotoxic T lymphocyte response to a wild-type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. Journal of Experimental Medicine 180, 933—943.
11. BERTOLETTI, A., SETTE, A., CHISARI, F. V., PENNA, A., LEVRERO, M., DE CARLI, M., FIACCADORI, F. & FERRARI, C. (1994). Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407–410.
12. BILSBOROUGH, J., CARLISLE, M. & GOOD, M. F. (1993). Identification of Caucasian CD4 T cell epitopes on the circumsporozoite protein of Plasmodium vivax: T cell memory. Journal of Immunology 151, 890—899.
13. BJORKMAN, P. J., SAPER, M. A., SAMRAOUI, B., BENNETT, W. S., STROMINGER, J. L. & WILEY, D. C. (1987). Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329, 506–512.
14. BLUM TIROUVANZIAM, U., SERVIS, C., HABLUETZEL, A., VALMORI, D., MEN, Y., ESPOSITO, F., DEL NERO, L., HOLMES, N., FASEL, N. & CORRADIN, G. (1995). Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. Journal of Immunology 154, 3922–3931.
15. CHAROENVIT, Y., COLLINS, W. E., JONES, T. R., MILLET, P., YUAN, L., CAMPBELL, G. H., BEAUDOIN, R. L., BRODERSON, J. R. & HOFFMAN, S. L. (1991). Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 251, 668–671.
16. CHICUREL, M., GAROIA, E. & GOODSAID, F. (1988). Modulation of macrophage lysosomal pH by Mycobacterium tuberculosis-derived proteins. Infection and Immunity 56, 479–483.
17. CONWAY, D. J., GREENWOOD, B. M. & McBRIDE, J. S. (1991). The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients. Parasitology 103, 1–6.
18. COUILLIN, I., CULMANN PENCIOLELLI, B., GOMARD, E., CHOPIN, J., LEVY, J. P., GUILLET, J. G. & SARAGOSTI, S. (1994). Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. Journal of Experimental Medicine 180, 1129–1134.
19. D’ALESSANDRO, U., LEACH, A., DRAKELEY, C. J., BENNETT, S., OLALEYE, B. O., FEGAN, G. W., JAWARA, M., LANGEROCK, P., GEORGE, M. O., TARGETT, G. A. & GREENWOOD, B. M. (1995). Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 346, 462–467.
20. DAME, J. B., WILLIAMS, J. L., McCUTCHAN, T. F., WEBER, J. L., WIRTZ, R. A., HOCKMEYER, W. T., MALOY, W. L., HAYNES, D., SCHNEIDER, I., ROBERTS, D., SANDERS, G. S., REDDY, E. P., DIGGS, C. L. & MILLER, L. H. (1984). Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 255, 593–599.
21. DAVENPORT, M. p. (1995). Antagonists or altruists: do viral mutants modulate T-cell responses? Immunology Today 16, 432–436.
22. DE CAMPOS LIMA, P. O., GAVIOLI, R., ZHANG, Q. J., WALLACE, L. E., DOLCETTI, R., ROWE, M., RICKINSON, A. B. & MASUCCI, M. G. (1993). HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11 + population. Science 260, 98–100. DE CAMPOS LIMA, P. O., LEVITSKY, V., BROOKS, J., LEE, S. P., HU, L. F., RICKINSON, A. B. & MASUCCI, M. G. (1994). T cell responses and virus evolution: loss of HLA A11-restricted OTL epitopes in Epstein—Barr virus isolates from highly All-positive populations by selective mutation of anchor residues. Journal of Experimental Medicine 179, 1297–1305.
23. DE LA CRUZ, V. F., LAL, A. A. & McCUTCHAN, T. F. (1987). Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum: implications for vaccine development. Journal of Biological Chemistry 262, 11935–11939.
24. DONG, T., BOYD, D., ROSENBERG, W., ALP, A., TAKIGUCHI, M., MCMICHAEL, A. & ROWLAND-JONES, S. (1996). An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. European Journal of Immunology 26, 335–339.
25. DOOLAN, D. L., HOUGHTEN, R. A. & GOOD, M. F. (1991). Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. International Immunology 3, 511–516.
26. DOOLAN, D. L., KHAMBOONRUANG, C., BECK, H. P., HOUGHTEN, R. A. & GOOD, M. F. (1993). Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally exposed endemic populations: analysis of human CTL response to most known variants. International Immunology 5, 37–46.
27. DOOLAN, D. L., SAUL, A. J. & GOOD, M. F. (1992). Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Infection and Immunity 60, 675–682.
28. DOOLAN, D. L., SEDEGAH, M., HEDSTROM, R. C., HOBART, P., CHAROENVIT, Y. & HOFFMAN, S. L. (1996). Circumventing genetic restriction of protection against Malaria with Multigene DNA Immunization: CD8+ T cell-, Interferon g-, and Nitric Oxide-dependent immunity. Journal of Experimental Medicine 183, 1739–1746.
29. EGAN, J. E., WEBER, J. L., BALLOU, W. R., HOLLINGDALE, M. R., MAJARIAN, W. R., GORDON, D. M., MALOY, W. L., HOFFMAN, S. L., WIRTZ, R. A., SCHNEIDER, I., WOOLLETT, G. R., YOUNG, J. F. & HOCKMEYER, W. T. (1987). Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 236, 453–456.
30. EVAVOLD, B. D. & ALLEN, P. M. (1991). Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252, 1308–1310.
31. EVAVOLD, B. D., SLOAN LANCASTER, J., HSU, B. L. & ALLEN, p. M. (1993). Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. Journal of Immunology 150, 3131–3140.
32. FALO, L. D., KOVACSOVICS-BANKOWSKI, M., THOMPSON, K. & ROCK, K. L. (1995). Targetting antigen into the phagocytic pathway in vivo induces protective immunity. Nature Medicine 1, 649–653.
33. FELL, A. H., CURRIER, J. & GOOD, M. F. (1994). Inhibition of Plasmodium falciparum growth in vitro by CD4+ and CD8+ T cells from non-exposed donors. Parasite Immunology 16, 579–586. GILBERT S. C. & HILL, A. v. s. (1997). Protein particle vaccines for malaria. Parasitology Today 13, 302–306.
34. GOLDBERG, A. L. & ROCK, K. L. (1992). Proteolysis, proteosomes and antigen presentation. Nature 357, 375–379.
35. GOOD, M. F., BERZOFSKY, J. A. & MILLER, L. H. (1988). The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development. Annual Review of Immunology 6, 663–668.
36. GOOD, M. F., MALOY, W. L., LUNDE, M. N., MARGALIT, H., CORNETTE, J. L., SMITH, G. L., MOSS, B., MILLER, L. H. & BERZOFSKY, J. A. (1987). Construction of synthetic immunogen: use of new T helper epitope on malaria circumsporozoite protein. Science 235, 1059–1062.
37. GOOD, M. F., POMBO, D., QUAKYI, I., RILEY, E. M., HOUGHTEN, R. A., MENON, A., ALLING, D. W., BERZOFSKY, J. A. & MILLER, L. H. (1988). Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proceedings of the National Academy of Sciences, USA 85, 1199–1203.
38. GRAVES, P. M., BHATIA, K., BURKOT, T. R., PRASAD, M., WIRTZ, R. A. & BECKERS, P. (1989). ASSOCIATION BETWEEN HLA TYPE AND ANTIBODY RESPONSE TO MALARIA SPOROZOITE AND GAMETOCYTE EPITOPES IS NOT EVIDENT IN IMMUNE PAGUA NEW GUINEANS. CLINICAL AND EXPERIMENTAL IMMUNOLOGY 78, 418–423. GUPTA, S. & HILL A. v. s. (1995). Dynamic interactions in malaria: host heterogeneity meets parasite polymorphism. Proceedings of the Royal Society of London Series B (Biological Sciences) 261, 271–277.
39. HEDSTROM, R. C., SEDEGAH, M. & HOFFMAN, S. L. (1994). Prospects and strategies for development of DNA vaccines against malaria. Research in Immunology 145, 476–483.
40. HERRINGTON, D., DAVIS, J., NARDIN, E., BEIER, M., CORTESE, J., EDDY, H., LOSONSKY, G., HOLLINGDALE, M., SZTEIN, M., LENNE, M., NUSSENZWEIG, R. S., CLYDE, D. & EDELMAN, R. (1991). Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. American Journal of Tropical Medicine and Hygiene 45, 539–547.
41. HILL, A. V. S., ALLSOPP, C. E. M., KWIATKOWSKI, D., ANSTEY, N. M., TWUMASI, P., ROWE, P. A., BENNETT, S., BREWSTER, D., McMICHAEL, A. J. & GREENWOOD, B. M. (1991). Common West African HLA antigens are associated with protection from severe malaria. Nature 352, 595–600.
42. HILL, A. V. S., ELVIN, J., WILLIS, A. C., AIDOO, M., ALLSOPP, C. E. M., GOTCH, F. M., GAO, X. M., TAKIGUCHI, M., GREENWOOD, B. M., TOWNSEND, A. R. M., McMICHAEL, A. j. & WHITTLE, H. c. (1992). Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434–439.
43. HOFFMAN, S. L., ISENBARGER, D., LONG, G. W., SEDEGAH, M., SZARFMAN, A., WATERS, L., HOLLINGDALE, M. R., VAN DER MEIDE, P. H., FINBLOOM, D. S. & BALLOU, W. R. (1989). Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244, 1078–1081. HOLLSBERG, P., WEBER, W. E., DANGOND, F., BATRA, V., SETTE, A. & HAFFLER, D. A. (1995). Differential activation of proliferation and cytotoxicity in human T cell lymphotropic virus type 1 Tax-specific CD8 T cells by on altered peptide ligand. Proceedings of the National Academy of Sciences, USA 92, 4036–4040.
44. HUGHES, A. L. (1991). Circumsporozoite protein genes of malaria parasites (Plasmodium spp.): evidence for positive selection on immunogenic regions. Genetics 127, 345–354.
45. HUGHES, A. L. & NEI, M. (1988). Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 335, 167–170.
46. ITESCU, S., MATHUR WAGH, U., SKOVRON, M. L., BRANCATO, L. J., MARMOR, M., ZELENIUCH JACQUOTTE, A. & WINCHESTER, R. (1992). HLA-B35 is associated with accelerated progression to AIDS. Journal of the Acquired Immunodeficiency Syndrome 5, 37–45.
47. JACOBS, P., RADZIOCH, D. & STEVENSON, M. M. (1996). A Thl-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infection and Immunity 64, 535–541.
48. JAMESON, S. C. & BEVAN, M. j. (1995). T cell receptor antagonists and partial agonists. Immunity 2, 1–11.
49. JAMESON, S. C., CARBONE, F. R. & BEVAN, M. J. (1993). Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. Journal of Experimental Medicine 177, 1541–1550.
50. KANEKO, T., MORIYAMA, T., UDAKA, K., HIROISHI, K., KITA, H., OKAMOTO, H., YAGITA, H., OKUMURA, K. & IMAWARI, M. (1997). Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope. European Journal of Immunology 27, 1782–1787.
51. KARIN, N., MITCHELL, D. J., BROCKE, S., LING, N. & STEINMAN, L. (1994). Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. Journal of Experimental Medicine 180, 2227–2237.
52. KASLOW, R. A., DUQUESNOY, R., VANRADEN, M., KINGSLEY, L., MARRARI, M., FRIEDMAN, H., SU, S., SAAH, A. J., DETELS, R., PHAIR, J. & RINALDO, C. (1990). Al, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicentre AIDS Cohort Study. Lancet 335, 927–930.
53. KLENERMAN, P., MEIER, U. C., PHILLIPS, R. E. & MCMICHAEL, A. j. (1995). The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. European Journal of Immunology 25, 1927—1931.
54. KLENERMAN, P., ROWLAND JONES, S., Me ADAM, S., EDWARDS, J., DAENKE, S., LALLOO, D., KOPPE, B., ROSENBERG, W., BOYD, D., EDWARDS, A., GIANGRANDE, P., PHILLIPS, R. & MCMICHAEL, A. (1994). Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369, 403–407.
55. KOVACSOVICS BANKOWSKI, M., CLARK, K., BENACERRAF, B. & ROCK, K. L. (1993). Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proceedings of the National Academy of Sciences, USA 90, 4942–4946.
56. KRAUSA, P., BRYWKA, M., SAVAGE, D., HUI, K. M., BUNCE, M., NGAI, J. L. F., TEO, D. L. T., ONG, Y. W., BAROUCH, D., ALLSOP, C. E. M., HILL, A. V. S., McMICHAEL, A. J., BODMER, J. G. & BROWNING, M. j. (1995). Genetic polymorphism within HLA-A#02: Significant allelic variation revealed in different populations. Tissue Antigens 45, 223–231.
57. KUMAR, A., ARORA, R., KAUR, P., CHAUHAN, V. S. & SHARM^ p. (1992). ‘Universal’ T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. Journal of Immunology 148, 1499–1505.
58. KWIATKOWSKI, D. (1990). Tumour necrosis factor, fever and fatality in falciparym malaria. Immunological Letters 25, 213–216.
59. KWI ATKOWSKI, D., HILL, A. V. S., SAMBOU, I., TWUMASI, P. CASTRACANE, J., MANOGUE, K. R., CERAMI, A., BREWSTER, D. R. & GREENWOOD, B. M. (1990). TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336, 1201–1204.
60. LOCKYER, M. J., MARSH, K. & NEWBOLD, C. I. (1989). Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. Molecular and Biochemical Parasitology 37, 275–280.
61. LOWIN, B., HAHNE, M., MATTMANN, C. & TSCHOPP, J. (1994). Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650–652.
62. MALIK, A., EGAN, J. E., HOUGHTEN, R. A., SADOFF, J. C. & HOFFMAN, S. L. (1991). Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proceedings of the National Academy of Sciences, USA 88, 3300–3304.
63. MARSH, K., HAYES, R. H., CARSON, D. C., OTOO, L. N., SHENTON, F., BYASS, P., ZAVALA, F. & GREENWOOD, B. M. (1988). Anti-sporozoite antibodies and immunity to malaria in a rural Gambian population. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 532–537.
64. McCUTCHAN, T. F., LAL, A. A., DO ROSARIO, V. & WATERS, A. p. (1992). Two types of sequence polymorphism in the circumsporozoite gene of Plasmodium falciparum. Molecular and Biochemical Parasitology 50, 37–46.
65. MCGUIRE, W., HILL, A. V. S., ALLSOPP, C. E. M., GREENWOOD, B. M. & KWIATKOWSKI, D. (1994). Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371, 508–511.
66. MELLOUK, S., GREEN, S. J., NACY, C. A. & HOFFMAN, S. L. (1991). IFN-gamma inhibits development of Plasmodium herghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. Journal of Immunology 146, 3971–3976.
67. MORENO, A., CLAVIJO, P., EDELMAN, R., DAVID, J., SZTEIN, M., SINIGAGLIA, F. & NARDIN, E. (1993). CD4 positive T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. Journal of Immunology 151, 489—499. NARDIN, E., CLAVIJO, P., MONS, B., VAN BELKUM, A., PONNUDURAI, T. & NUSSENZWEIG, R. S. (1991). T Cell epitopes of the circumsporozoite protein of Plasmodium vivax: recognition by lymphocytes of a sporozoite-immunized chimpanzee. Journal of Immunology 146, 1674—1678.
68. NARDIN, E., MUNESINGHE, Y. D., MORENO, A., CLAVIJO, P., CALLE, M. C., EDELMAN, Q.H.R., DAVIS, J., HERRINGTON, D. & NUSSENZWEIG, R. s. (1992). T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites. Memorias do Institutio Oswaldo Cruz 3, 223–227.
69. NARDIN, E. H. & NUSSENZWEIG, R. S. (1993). T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annual Review of Immunology 11, 687–727.
70. NOSTEN, F., LUXEMBURGER, C., KYLE, D. E., BALLOU, W. R., WITTES, J., WAH, E., CHONGSUPHAJAISIDDHI, T., GORDON, D. M., WHITE, N. J., SADOFF, J. C. & HEPPNER, D. G. (1996). Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group. Lancet 348, 701–707.
71. NUSSLER, A., PIED, S., GOMA, J., RENIA, L., MILTGEN, F., GRAU, G. E. & MAZIER, D. (1991). TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6. International Immunology 3, 317–321.
72. PHILLIPS, R. E., ROWLAND JONES, S., NIXON, D. F., GOTCH, F. M., EDWARDS, J. P., OGUNLESI, A. O., ELVIN, J. G., ROTHBARD, J. A., BANGHAM, C.R., RIZZA, C.R. & MCMICHAEL, A. j. (1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453–459.
73. PLEBANSKI, M., AIDOO, M., WHITTLE, H. C. & HILL, A. V. S. (1997). Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. Journal of Immunology 158, 2849–2855.
74. PLEBANSKI, M., ALLSOPP, C. E. M., AIDOO, M., REYBURN, H. & HILL, A. v. s. (1995). Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood. European Journal of Immunology 25, 1783–1787.
75. QARI, S. H., COLLINS, W. E., LOBEL, H. O., TAYLOR, F. & LAL, A. A. (1994). A study of polymorphism in the circumsporozoite protein of human malaria parasites. American Journal of Tropical Medicine and Hygiene 50, 45–51.
76. QUAKYI, I. A., OTOO, L. N., POMBO, D., SUGARS, L. Y., MENON, A., DEGROOT, A. S., JOHNSON, A., ALLING, D., MILLER, L. H. & GOOD, M. F. (1989). Differential non-responsiveness in humans of candidates Plasmodium falciparum vaccine antigens. American Journal of Tropical Medicine and Hygiene 41, 125—134.
77. RAMMENSEE, H. G. (1995). Chemistry of peptides associated with MHC class I and class II molecules. Current Opinions in Immunology 7, 85–96.
78. RAMMENSEE, H. G., FRIEDE, T. & STEVANOVIIC, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178–228.
79. RANI, R., FERNANDEZ-VINA, M. A., ZAHEER, S. A., BEENA, K. R. & STASTNY, p. (1993). Study of HLA class II alleles by PCR oligotyping in leprosy patients from North India. Tissue Antigens 42, 133–137.
80. REISESOUSA, C. & GERMAIN, R. N. (1995). Major Histocompatibility Complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. Journal of Experimental Medicine 182, 841–851.
81. RODRIGUES, M., NUSSENZWEIG, R. S. & ZAVALA, F. (1993). The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology 80, 1–5.
82. ROMERO, P., EBERL, G., CASANOVA, J.-L., CORDEY, A.-S., WINDMANN, C., LUESCHER, I. F., CORRADIN, G. & MARYANSKI, J. L. (1992). Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Journal of Immunology 148, 1871–1878.
83. ROMERO, P., MARYANSKI, J. L., CORRADIN, G., NUSSENZWEIG, R. S., NUSSENZWEIG, V. & ZAVALA, F. (1989). Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341, 323–326.
84. SCHERLE, P. A. & GERHARD, w. (1986). Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. Journal of Experimental Medicine 164, 1114–1128.
85. SCHODEL, F., KELLY, S. M., PETERSON, D. L., MILICH, D. R. & CURTISS, R. R. (1994). Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infection and Immunity 62, 1669–1676.
86. SEDEGAH, M., HEDSTROM, R., HOBART, P. & HOFFMAN, S. L. (1994). Protection against malaria by immunisation with plasmid DNA encoding circumsporozoite protein. Proceedings of the National Academy of Sciences, USA 91, 9866–9870.
87. SETTE, A., ALEXANDER, J., RUPPERT, J., SNOKE, K., FRANCO, A., ISHIOKA, G.& GREY, H. M. (1994). Antigen analogs/MHC complexes as a specific T cell receptor antagonists. Annual Review of Immunology 12, 413–431.
88. SHI, Y. P., ALPERS, M. P., POVOA, M. M. & LAL, A. A. (1992). Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falcon's parasites from malaria-endemic regions of Papua New Guinea and Brazil. American Journal of Tropical Medicine and Hygiene 47, 844–851.
89. STEEL, C. M., LUDLAM, C. A., BEATSON, D., PEUTHERER, J. F., CUTHBERT, R. J., SIMMONDS, P., MORRISON, H. & JONES, M. (1988). HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1, 1185–1188.
90. STOUTE, J. A., SLAOUI, M., HEPPNER, G., MOMIN, P., KESTER, K. E., DESMONS, P., WELLDE, B. T., GARCON, N., KRZYCH, U., MARCHAND, M., BALLOU, R. & COHEN, J. (1997). A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium Falciparum malaria. New England Journal of Medicine 336, 86–91.
91. TINE, J. A., LANAR, D. E., SMITH, D. M., WELLDE, B. T., SCHULTHEISS, P., WARE, L. A., KAUFFMAN, E. B., WIRTZ, R. A., DE TAISNE, C., HUI, G. S. N., CHANG, S. P., CHURCH, P., HOLLINGDAKE, M. R., KASLOW, D. C., HOFFMAN, S., GUITO, K. P., BALLOU, W. R., SADOFF, J. C. & PAOLETTI, E. (1996). NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium Falciparum malaria. Infection and Immunity 64, 3833–3844.
92. TOWNSEND, A. & TROWSDALE, j. (1993). The transporters associated with antigen presentation. Seminars in Cell Biology 257, 927–934.
93. UDHAYAKUMAR, V., ANYONA, D., KARIUKI, S., SHI, Y. P., BLOLAND, P. B., BRANCH, O. H., WEISS, W., NAHLEN, B. L., KASLOW, D. C. & LAL, A. L. (1995). Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium Falciparum merozoite surface protein (MSP). 1. Journal of Immunology 154, 6022–6030.
94. UDHAYAKUMAR, V., SHI, Y. P., KUMAR, S., JUE, D. L., WOHLHUETER, R. M. & LAL, A. A. (1994). Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic T-cell recognition. Infection and Immunity 62, 1410–1413.
95. VAESSEN, R. T., HOUWELING, A. & VAN DER EB, A. J. (1987). Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science 235, 1486–1488.
96. WANG, R., CHAROENVIT, Y., CORRADIN, G., PORROZZI, R., HUNTER, R. L., GLENN, G., ALVING, C.R., CHURCH, P. & HOFFMAN, S. L. (1995). Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. Journal of Immunology 154, 2784–2793.
97. WINDMANN, C., ROMERO, P., MARYANSKI, J. L., CORRADIN, G. & VALMORI, D. (1992). T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. Journal of Immunological Methods 155, 95–99.
98. YOSHIDA, N., DI SANTI, S. M., DUTRA, A. P., NUSSENZWEIG, R. S., NUSSENZWEIG, V. & ENEA, v. (1990). Plasmodium falciparum: restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil. Experimental Parasitology 71, 386—392.
99. YOUNG, J. F., HOCKMEYER, W. T., GROSS, M., BALLOU, W. R., WIRTZ, R. A., TROSPER, J. H., BEAUDOIN, R. L., HOLLINGDALE, M. R., MILLER, L. H., DIGGS, C. L. & ROSENBERG, M. (1985). Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science 228, 958–962.
100. ZAVALA, F., TAM, J. P., HOLLINGDALE, M. R., COCHRANE, A. H., QUAKYI, I., NUSSENZWEIG, R. S. & NUSSENZWEIG, V. (1985). Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228, 1436–1440.
101. ZEVERING, Y., KHAMBOONRUANG, C., RUNGRUENGTHANAKIT, K., TUNGVIBOONCHAI, L., RUENGPIPATTANAPAN, J., BATHURST, I., BARR, P. & GOOD, M. F. (1994). Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax. Proceedings of the National Academy of Sciences, USA 91, 6118–6122.